Moneycontrol
Nov 10, 2017 04:40 PM IST | Source: CNBC-TV18

Approach is to take products global; expect margins to improve: Laurus Labs

Laurus Labs posted a rather subdued set of Q2 earnings. The revenue and profit have come in flat this quarter. In an interview to CNBC-TV18, Satyanarayana Chava, Founder & CEO of the company spoke about results and his outlook going ahead.

CNBC TV18 @moneycontrolcom

.Laurus Labs posted a rather subdued set of Q2 earnings. The revenue and profit have come in flat this quarter. In an interview to CNBC-TV18, Satyanarayana Chava, Founder & CEO of the company spoke about results and his outlook going ahead.

Quarter-on-quarter (QoQ) growth was good but if we compare Q2FY18 versus Q2FY17, then the growth was small, said Chava.

Talking about US market, he said by next financial year they would have four approved and launched molecules in the US.

On margin front, he said they  would improve as and when they start getting revenues from new unitsy

He further said that they have filed dossiers in Canada, Europe, with World Health Organization (WHO) and also in South Africa. Our approach is to take products global.

Watch accompanying video for more details.
Sections
Follow us on
Available On